Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
851
DELISTED
Interxion Holding N.V.
INXN
| $18.5M | 0.03% |
467,400
-70,700
| -13% | -$2.71M |
|
852
ON Semiconductor
ON
$32.4B
| $18.4M | 0.03% |
1,188,796
-855,764
| -42% | -$12.4M |
|
853
Pool Corp
POOL
$7.25B
| $18.4M | 0.03% |
153,836
-133,815
| -47% | -$15M |
|
|
NUTR
854
DELISTED
Nutraceutical International Co
NUTR
| $18.3M | 0.03% |
588,600
+37,100
| +7% | +$1.26M |
|
|
CKH
855
DELISTED
Seacor Holdings Inc.
CKH
| $18.3M | 0.03% |
273,907
-6,927
| -2% | -$473K |
|
856
Middlesex Water
MSEX
$1.1B
| $18.3M | 0.03% |
496,000
+40,800
| +9% | +$1.52M |
|
|
BBT
857
Beacon Financial Corp
BBT
$2.69B
| $18.3M | 0.03% |
508,157
+91,076
| +22% | +$3.22M |
|
858
Idacorp
IDA
$8.21B
| $18.3M | 0.03% |
220,770
+109,870
| +99% | +$8.86M |
|
|
NAVG
859
DELISTED
Navigators Group Inc
NAVG
| $18.3M | 0.03% |
337,292
+68,292
| +25% | +$3.81M |
|
|
SYKE
860
DELISTED
SYKES Enterprises Inc
SYKE
| $18.3M | 0.03% |
621,573
-114,507
| -16% | -$3.26M |
|
861
Hubbell
HUBB
$27.1B
| $18.3M | 0.03% |
152,100
-50,700
| -25% | -$6.09M |
|
|
RST
862
DELISTED
ROSETTA STONE INC
RST
| $18.3M | 0.03% |
1,872,000
+83,300
| +5% | +$701K |
|
863
Camden Property Trust
CPT
$10.9B
| $18.2M | 0.03% |
226,400
+218,700
| +2,840% | +$18M |
|
864
Cohen & Steers
CNS
$4.36B
| $18.2M | 0.03% |
455,300
-126,000
| -22% | -$4.56M |
|
865
Landstar System
LSTR
$6.31B
| $18.2M | 0.03% |
212,340
+88,700
| +72% | +$7.58M |
|
|
VR
866
DELISTED
Validus Hold Ltd
VR
| $18M | 0.03% |
319,734
+53,670
| +20% | +$3.06M |
|
867
AptarGroup
ATR
$8.47B
| $18M | 0.03% |
234,100
+97,700
| +72% | +$7.3M |
|
|
FUEL
868
DELISTED
Rocket Fuel Inc.
FUEL
| $18M | 0.03% |
3,353,300
+375,300
| +13% | +$1.09M |
|
869
Watsco Inc
WSO
$12.8B
| $18M | 0.03% |
125,400
+69,200
| +123% | +$10.4M |
|
870
Bio-Rad Laboratories Class A
BIO
$9.68B
| $17.9M | 0.03% |
90,000
+58,800
| +188% | +$11.3M |
|
871
IDT Corp
IDT
$1.63B
| $17.9M | 0.03% |
1,663,189
+30,485
| +2% | +$448K |
|
|
NSA
872
DELISTED
National Storage Affiliates Trust
NSA
| $17.9M | 0.03% |
747,100
+389,200
| +109% | +$9.03M |
|
873
Lesaka Technologies
LSAK
$408M
| $17.8M | 0.02% |
1,457,200
-125,500
| -8% | -$1.58M |
|
|
STL
874
DELISTED
Sterling Bancorp
STL
| $17.8M | 0.02% |
750,409
+503,859
| +204% | +$12.1M |
|
|
CYOU
875
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $17.8M | 0.02% |
633,300
+12,500
| +2% | +$330K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.